Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04069429 · ClinicalTrials.gov registry record · Early Phase 1
Radiation Dose in Humans From Orally Administered Tc99m-Heparin
A Early Phase 1 study of Eosinophilic Esophagitis, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04069429: Completed Early Phase 1 study of Eosinophilic Esophagitis, sponsored by University of Utah.
NCT04069429 is a Early Phase 1 study of Eosinophilic Esophagitis that has completed, run by University of Utah. The registered enrollment target is 8 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04069429, a Early Phase 1 study of Eosinophilic Esophagitis, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study of a new agent used for evaluation of inflammation in the GI tract. This agent is investigational and thus is being studied to determine appropriate dosing and administration in both normal controls (i.e. people without gastrointestinal complaints) and patients with eosinophilic disease (i.e. those with an immune reaction and inflammation in their bodies with a certain cell called an eosinophil). The study will test whether the radiolabeled agent will bind to the inflammation of eosinophilic esophagitis patients because an animal model of eosinophilic esophagitis which shows the striking deposition of eosinophil granule proteins is not available.
Primary Outcome
Biodistribution of Tc99m-heparin to the esophagus and other organs, especially of the gastrointestinal tract as judged by planar scans and by single photon emission computed tomography scans.
Conditions Studied
Interventions
- PROCEDURE Esophagogastroduodenoscopy
- RADIATION Computerized Tomography scan
- RADIATION Single Photon Emission Computed Tomography scans
- DRUG Technetium Tc 99M
- RADIATION Planar Images
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2016-07 |
| Est. Completion | 2020-10 |
| Phase | Early Phase 1 |
What the finished NCT04069429 record still lists
NCT04069429 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 5 interventions - of which Esophagogastroduodenoscopy is the first listed.
NCT04069429 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT04069429 about?
NCT04069429 is a clinical study titled "Radiation Dose in Humans From Orally Administered Tc99m-Heparin". This is a research study of a new agent used for evaluation of inflammation in the GI tract. This agent is investigational and thus is being studied to determine appropriate dosing and administration in both normal controls (i.e. people without gastrointestinal complaints) and patients with eosinoph...
What is the current status of trial NCT04069429?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2016-07. Estimated completion is 2020-10.
What conditions does trial NCT04069429 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis.
What interventions are being tested in trial NCT04069429?
The interventions under investigation include: Esophagogastroduodenoscopy (PROCEDURE), Computerized Tomography scan (RADIATION), Single Photon Emission Computed Tomography scans (RADIATION), Technetium Tc 99M (DRUG), Planar Images (RADIATION).
Who is sponsoring clinical trial NCT04069429?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04069429 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04069429's enrollment target sits among peer trials
8 44th of 44 higher than 1 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Registry for the Food Allergy Community
RECRUITING
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
Eosinophilic Gastrointestinal Disorders Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia